Company Filing History:
Years Active: 2006
Title: Scott Loiler: Innovator in Recombinant AAV Virion Production
Introduction
Scott Loiler is a notable inventor based in Gainesville, FL (US). He has made significant contributions to the field of biotechnology, particularly in the production of recombinant AAV virions. His work has implications for gene therapy and other medical applications.
Latest Patents
Scott Loiler holds a patent for the "Production of pseudotyped recombinant AAV virions." This patent involves vectors that encode Adeno-Associated Virus (AAV) Rep and Cap proteins of different serotypes, along with Adenovirus transcription products that provide necessary helper functions. The purification methods he developed generated pseudotyped rAAV virion stocks that were 99% pure, with titers of 1×10–1×10 vector genomes/ml.
Career Highlights
Scott Loiler is affiliated with the University of Florida Research Foundation, Incorporated. His work at this institution has allowed him to explore innovative methods in the production of viral vectors, which are crucial for advancing gene therapy techniques.
Collaborations
Throughout his career, Scott has collaborated with esteemed colleagues such as Richard O Snyder and Sergei Zolotukhin. These partnerships have enhanced the research and development of his innovative projects.
Conclusion
Scott Loiler's contributions to the field of biotechnology, particularly in the production of recombinant AAV virions, highlight his role as an influential inventor. His work continues to pave the way for advancements in gene therapy and related medical fields.